Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
V-type proton ATPase subunit H (ATP6V1H) is a pivotal regulatory subunit of the V1 complex in vacuolar ATPases (V-ATPase), enzymes essential for acidifying various intracellular organelles in eukaryotic cells, including endosomes, lysosomes, and synaptic vesicles. Proper acidification mediated by V-ATPase is critical for processes such as protein sorting, activation of precursor enzymes (zymogens), formation of proton gradients, and receptor-mediated endocytosis. The subunit H is vital for the enzyme’s activity, though not required for its assembly, and defects or alterations in its function are linked to disorders such as lateral meningocele syndrome, osteogenesis imperfecta type V, and may contribute to metabolic diseases including type 2 diabetes. Drugs such as tiludronic acid may act as V-ATPase inhibitors, although their pharmacological details regarding ATP6V1H are not comprehensively established.
Inhibition of V-ATPase proton transport
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on V-type proton ATPase subunit H (ATP6V1H).